Travis Larson

This study shows that the alpha 1-adrenergic antagonist terazosin enhances glycolysis and is neuroprotective in Alzheimer's disease by reducing amyloid pathology and slowing cognitive decline.

This study examines interval timing deficits in P301S tau transgenic mice, finding they consistently underestimate temporal intervals compared to wild-type controls.

This study investigates whether cortical injection of alpha-synuclein preformed fibrils (PFF) affects interval timing in mice, finding no consistent deficits despite synucleinopathy.

This study investigates how scopolamine affects interval timing in mice by examining changes in medial frontal cortex activity, finding that it impairs timing but does not alter time-related ramping.